Insider Selling: Kewaunee Scientific Co. (NASDAQ:KEQU) VP Sells 3,470 Shares of Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff sold 3,470 shares of the firm’s stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $65.50, for a total value of $227,285.00. Following the sale, the vice president now owns 5,000 shares in the company, valued at $327,500. This trade represents a 40.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Kewaunee Scientific Price Performance

NASDAQ KEQU traded down $1.63 during trading hours on Thursday, hitting $60.24. 11,717 shares of the company’s stock traded hands, compared to its average volume of 18,181. The company has a market capitalization of $173.01 million, a PE ratio of 9.55 and a beta of 0.80. The firm’s 50-day moving average is $44.44 and its 200-day moving average is $43.76. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $67.20. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00.

Institutional Trading of Kewaunee Scientific

Hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after buying an additional 900 shares during the last quarter. Barclays PLC purchased a new stake in shares of Kewaunee Scientific in the 3rd quarter valued at approximately $121,000. Heron Bay Capital Management acquired a new position in shares of Kewaunee Scientific in the 2nd quarter worth approximately $252,000. State Street Corp acquired a new stake in Kewaunee Scientific in the 3rd quarter valued at approximately $266,000. Finally, Ritholtz Wealth Management raised its position in Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the period. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.